Search

Your search keyword '"Carmisciano L"' showing total 130 results

Search Constraints

Start Over You searched for: Author "Carmisciano L" Remove constraint Author: "Carmisciano L"
130 results on '"Carmisciano L"'

Search Results

2. P033 The assessment of serum cytokines at baseline could predict mucosal healing in patients with Crohn's disease treated with ustekinumab. A prospective study

3. P678 Ustekinumab therapy improves the nutritional status in patients with Crohn's Disease. A prospective study

4. Signs and symptoms of COVID-19 in patients with multiple sclerosis

5. Nonlesional Sources of Contrast Enhancement on Postgadolinium “Black-Blood” 3D T1-SPACE Images in Patients with Multiple Sclerosis

8. Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies

10. The outcome of a national MS-Covid-19 study: What the Turkish MS cohort reveals?

11. DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France: a pooled analysis from Italy and France

12. Disease modifying therapies and Covid‐19 severity in Multiple Sclerosis

17. Lifestyle and Mediterranean diet adherence in a cohort of Southern Italian patients with Multiple Sclerosis

19. Assessing upper limb function in multiple sclerosis using an engineered glove

22. Usefulness of the ‘two‐step method’ of digital follow‐up for early‐stage melanoma detection in high‐risk French patients: a retrospective 4‐year study

25. Effect of SARS-CoV-2 mRNA vaccination in multiple sclerosis patients treated with disease modifying therapies

26. 3 Young Investigator Awardee - Intermediate clinical endpoints in early-stage breast cancer: an analysis of individual patient data from the Gruppo Italiano Mammella (GIM) and Mammella Intergruppo trials (MIG).

27. The effect of air pollution on COVID‐19 severity in a sample of patients with multiple sclerosis

28. Lifestyle and Mediterranean diet adherence in a cohort of Southern Italian patients with Multiple Sclerosis

29. Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

30. A snapshot on patient-reported outcome measures of people with multiple sclerosis on first-line therapies in a real world setting

31. Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib

32. Sacubitril/valsartan in real-life European patients with heart failure and reduced ejection fraction: a systematic review and meta-analysis

33. SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study

34. COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context

35. Digital work engagement among Italian neurologists

36. First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study

37. Composite Prediction Score to Interpret Bone Focal Uptake in Hormone-Sensitive Prostate Cancer Patients Imaged with [ 18 F]PSMA-1007 PET/CT.

38. Association of inflammatory markers with incident heart failure or cancer in the HUNT3 and Health ABC population studies.

39. Characterization of HER2-low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study.

40. Creating an automated tool for a consistent and repeatable evaluation of disability progression in clinical studies for multiple sclerosis.

41. MRI assessment of seminal vesicle involvement by prostate cancer using T2 signal intensity and volume.

42. Baseline Assessment of Serum Cytokines Predicts Clinical and Endoscopic Response to Ustekinumab in Patients With Crohn's Disease: A Prospective Pilot Study.

43. Intermediate clinical endpoints in early-stage breast cancer: an analysis of individual patient data from the Gruppo Italiano Mammella and Mammella Intergruppo trials.

44. Biometry extraction and probabilistic anatomical atlas of the anterior Visual Pathway using dedicated high-resolution 3-D MRI.

45. Response to Ustekinumab Therapy Is Associated with an Improvement of Nutritional Status in Patients with Crohn's Disease.

46. Trans-synaptic degeneration in the optic pathway: Exploring the role of lateral geniculate nucleus in early stages of relapsing-remitting multiple sclerosis.

47. Oncoplastic level II volume displacement surgery for breast cancer: oncological and aesthetic outcomes.

48. Improvement in quality of life and sexual function in patients affected by vulvar lichen sclerosus treated with combined autologous platelet-rich plasma and fat grafting.

49. Clinical and MRI measures to identify non-acute MOG-antibody disease in adults.

50. Linguistic profile automated characterisation in pluripotential clinical high-risk mental state (CHARMS) conditions: methodology of a multicentre observational study.

Catalog

Books, media, physical & digital resources